Loading…
Reported covered position: 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972- Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2014 · second_quarter · Q2
General health issues, including, but not limited to, coverage and reimbursement; drug imporation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486); Safeguarding America's Pharmaceuticals Act of 2013
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Source: Senate LDA
| NOVARTIS CORPORATION |
| 8 |
| 2011–2013 |
| PROFESSIONAL COMPOUNDING CENTERS OF AMERICA | 8 | 2012–2014 |
| ROCK & ASSOCIATES | 6 | 2013–2014 |
| WELLNESS PHARMACY | 6 | 2013–2014 |
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972- Cutting Costly Codes Act of 2013
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health issues, including, but not limited to, coverage and reimbursement; drug imporation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486); Safeguarding America's Pharmaceuticals Act of 2013
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Protect Medical Innovation Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Medical Device Access and Innovation Protection Act
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Stop Corporate Inversions Act of 2014
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
Medical Device Tax Repeal; Stop Corporate Inversions Act, S.2360 and H.R. 4679; issues relating to incentives for life sciences research; Protect Medical Innovation Act of 2013, S.232, H.R. 523
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972- Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Expanding Patients' Access to Quality Care Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Compounding Clarity Act of 2013
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Compounding Clarity Act of 2013
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Compounding Clarity Act of 2013
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Compounding Clarity Act of 2013
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Drug Quality and Security Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Drug Quality and Security Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Drug Quality and Security Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Drug Quality and Security Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
National Defense Authorization Act, HR 4310
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Compounding pharmacy and FDA issues; S959, Pharmaceutical Compounding Quality & Accountability Act
Pharmaceutical Quality, Security, and Accountability Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Pharmaceutical Quality, Security, and Accountability Act
Client: PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Firm: CAPITOL HILL CONSULTING GROUP
Compounding pharmacy and FDA issues Pharmaceutical Compounding Quality and Accounting Act (S. 959)
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Compounding pharmacy and FDA issues; S959, Pharmaceutical Compounding Quality & Accountability Act
Pharmaceutical Quality, Security, and Accountability Act
Client: ROCK & ASSOCIATES · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Pharmaceutical Quality, Security, and Accountability Act
Client: WELLNESS PHARMACY · Firm: CAPITOL HILL CONSULTING GROUP
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Cutting Costly Codes Act of 2013
Client: MCBRIDE ORTHOPEDIC HOSPITAL · Firm: CAPITOL HILL CONSULTING GROUP
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) Stop Tampering of Prescription Pills Act of 2012 (H.R. 6160)
Life Sciences Jobs and Investment Act of 2011
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation
Life Sciences Jobs and Investment Act of 2011
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation; H.R. 6160, Stop Tampering of Prescription Pills Act of 2012.
Life Sciences Jobs and Investment Act of 2011
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S.1410; the Life Sciences Jobs and Investment Act of 2011; biosimiliars; prescription and generic drug user fees legislation
Life Sciences Jobs and Investment Act of 2011
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation
Stop Tampering of Prescription Pills Act of 2012
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation; H.R. 6160, Stop Tampering of Prescription Pills Act of 2012.
Stop Tampering of Prescription Pills Act of 2012
Client: PURDUE PHARMA LLP · Firm: CAPITOL HILL CONSULTING GROUP
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) Stop Tampering of Prescription Pills Act of 2012 (H.R. 6160)
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
Life Sciences Jobs and Investment Act of 2011
Client: ENDO PHARMACEUTICALS · Firm: CAPITOL HILL CONSULTING GROUP
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S.1410, the Life Sciences Jobs and Investment Act of 2011
general Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2014 · second_quarter · Q2
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General issues relating to physicians and hospitals HR 2027- Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972- Cutting Costly Codes Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORACLE via CAPITOL HILL CONSULTING GROUP
2014 · second_quarter · Q2
general higher education issues
corporate and international tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2014 · second_quarter · Q2
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
General health issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; issues relating to prescription drug abuse; Canada compliance issues
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2014 · second_quarter · Q2
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via CAPITOL HILL CONSULTING GROUP
2014 · second_quarter · Q2
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2014 · second_quarter · Q2
Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
Tax reform and charitable giving
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; SGR
General health care issues pertaining to OSU CHS
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
Tax reform and charitable giving
General homeland security issues
General transportation issues
ORACLE via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
General higher education issues
Corporate and international tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
Device Tax Repeal; General Corporate Tax Reform
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Drug Safety. Issues relating to prescription drug abuse.
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2014 · first_quarter · Q1
General Medicare issues including, but not limited to, coverage and reimbursement
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; SGR
Federal Student Loans/Aid
Tax reform and charitable giving
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
General transportation issues
2014 Defense Authorization bill
Tax reform and charitable giving
General education issues; Federal Student Loans/Aid
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Device Tax Repeal; General Corporate Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
General Medicare issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Drug Safety.
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORACLE via CAPITOL HILL CONSULTING GROUP
2013 · fourth_quarter · Q4
General higher education issues
Corporate and international tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Drug Safety.
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
General transportation issues
2014 Defense Authorization bill
General agriculture issues Federal research/competitive grants
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
Federal Student Loans/Aid
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; SGR
General health care issues pertaining to OSU-CHS
ORACLE via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
General higher education issues
Corporate and international tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
General Medicare issues including, but not limited to, coverage and reimbursement
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
Device Tax Repeal; General Corporate Tax Reform
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2013 · third_quarter · Q3
Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
Compounding pharmacy and FDA issues; S959, Pharmaceutical Compounding Quality & Accountability Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
Compounding pharmacy and FDA issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
Tax reform and charitable giving
2014 Defense Authorization bill
General education issues
General transportation issues
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
Tax reform and charitable giving
General health care issues pertaining to OSU-CHS
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Graduate Medical Education funding; SGR
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
Device Tax Repeal; General Corporate Tax Reform
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
General Medicare issues including, but not limited to, coverage and reimbursement
General issues relating to physicians and hospitals HR 2027 - Expanding Patients' Access to Quality Care Act of 2013 HR 1701 and S. 972 - Cutting Costly Codes Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
Compounding pharmacy and FDA issues Pharmaceutical Compounding Quality and Accounting Act (S. 959)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Drug Safety.
Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
General corporate tax reform; Orphan Drug Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORACLE via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · Q2
National Defense Authorization Act
Corporate and international tax reform
General higher education issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELLNESS PHARMACY via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · RR
Compounding pharmacy and FDA issues; S959, Pharmaceutical Compounding Quality & Accountability Act
ROCK & ASSOCIATES via CAPITOL HILL CONSULTING GROUP
2013 · second_quarter · RR
Compounding pharmacy and FDA issues
ORACLE via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
General higher education issues
Corporate and international tax reform
National Defense Authorization Act, HR 4310
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · 1A
General corporate tax reform; Orphan Drug Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
General corporate tax reform; Orphan Drug Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; biosimiliars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Device Tax Repeal; General Corporate Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Drug Safety.
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues pertaining to OSU-CHS, including, but not limited to, information technology; access provider education; and, veteran's health care.
General appropriations for OSU-CHS; Labor, HHS, Education Appropriations bills; CJS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
General education issues, no specific bills
General appropriations for the University; FY 2014 Appropriations for agriculture, commerce, justice, science, defense, energy and water; financial services; Homeland Security reauthorization; Interior and Environment; Labor, HHS, and Education; Highway Reauthorization
General transportation issues
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
General issues relating to physicians and hospitals
General Medicare issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2013 · first_quarter · Q1
Compounding pharmacy and FDA issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · 4A
General agriculture isses
General transportation issues
General education issues, no specific bills
General homeland security issues
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
Compounding pharmacy and FDA issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORACLE via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
Issues related to tax code legislation; the president's tax and budget proprosals; Chairman Camp international tax draft; National Defense Authorization Act, HR 4310.
General higher education issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation; H.R. 6160, Stop Tampering of Prescription Pills Act of 2012.
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Prescription and Generic Drug User Fees legislation; Public Health Service Act (42 USC 6A); Biosimilars; Patient Protection and Affordable Care Act (P.L. 111-148)
General patent issues; America Invents Act (S. 23)
H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
General health care issues pertaining to OSU-CHS, including, but not limited to, information technology; access provider education; and, veteran's health care.
General appropriations for OSU-CHS; Labor, HHS, Education Appropriations bills; CJS Appropriations bill
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
General homeland security issues
General education issues, no specific bills
General agriculture isses
General transportation issues
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; Prescription and Generic Drug User Fee legislation
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) Stop Tampering of Prescription Pills Act of 2012 (H.R. 6160)
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · Q4
General issues relating to physicians and hospitals
General Medicare issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA via CAPITOL HILL CONSULTING GROUP
2012 · fourth_quarter · RR
Compounding pharmacy and FDA issues
Compounding pharmacy and FDA issues
Compounding pharmacy and FDA issues
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2012 · third_quarter · Q3
H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Prescription and Generic Drug User Fees legislation; Public Health Service Act (42 USC 6A); Biosimilars; Patient Protection and Affordable Care Act (P.L. 111-148)
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2012 · third_quarter · Q3
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2012 · third_quarter · Q3
General Medicare issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2012 · third_quarter · Q3
General agriculture isses
General homeland security issues
General education issues, no specific bills
General transportation issues
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2012 · third_quarter · Q3
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues pertaining to OSU-CHS, including, but not limited to, information technology; access provider education; and, veteran's health care.
General appropriations for OSU-CHS; Labor, HHS, Education Appropriations bills; CJS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2012 · third_quarter · Q3
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; Prescription and Generic Drug User Fee legislation
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORACLE via CAPITOL HILL CONSULTING GROUP
2012 · third_quarter · Q3
Issues related to tax code legislation; the president's tax proprosals; HR-1834, Freedom to Invest Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORACLE via CAPITOL HILL CONSULTING GROUP
2012 · second_quarter · Q2
Issues related to tax code legislation; the President's tax proprosals; HR-1834, Freedom to Invest Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2012 · second_quarter · Q2
General Medicare issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2012 · second_quarter · Q2
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2012 · second_quarter · Q2
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; Prescription and Generic Drug User Fee legislation
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2012 · second_quarter · Q2
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010
General patent issues; America Invents Act (S. 23)
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2012 · second_quarter · Q2
General transportation issues
General homeland security issues
General education issues, no specific bills
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2012 · second_quarter · Q2
General health care issues pertaining to OSU-CHS, including, but not limited to, information technology; access provider education; and, veteran's health care.
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General appropriations for OSU-CHS; Labor, HHS, Education Appropriations bills; CJS Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2012 · first_quarter · Q1
General Medicare issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2012 · first_quarter · Q1
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2012 · first_quarter · Q1
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Biosimilars; Patient Protection and Affordable Care Act (P.L. 111-148)
H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2012 · first_quarter · 1A
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S.1410; the Life Sciences Jobs and Investment Act of 2011; biosimiliars; prescription and generic drug user fees legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OKLAHOMA STATE UNIVERSITY via CAPITOL HILL CONSULTING GROUP
2012 · first_quarter · Q1
General appropriations for the University; FY2012 Appropriations for agriculture, commerce, justice, science, defense, energy and water; financial services; Homeland Security reauthorization; Interior and Environment; Labor, HHS, and Education; Highway Reauthorization
General homeland security issues
General education issues, no specific bills
OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES via CAPITOL HILL CONSULTING GROUP
2012 · first_quarter · Q1
General appropriations for OSU-CHS; Labor, HHS, Education Appropriations bills; CJS Appropriations bill
General health care issues pertaining to OSU-CHS, including, but not limited to, information technology; access provider education; Veteran's health care; American Recovery and Reinvestment Act (H.R. 1)
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCBRIDE ORTHOPEDIC HOSPITAL via CAPITOL HILL CONSULTING GROUP
2012 · first_quarter · RR
General medicare issues including, but not limited to, coverage and reimbursement
ENDO PHARMACEUTICALS via CAPITOL HILL CONSULTING GROUP
2011 · fourth_quarter · 4A
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S.1410, the Life Sciences Jobs and Investment Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LLP via CAPITOL HILL CONSULTING GROUP
2011 · fourth_quarter · Q4
Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via CAPITOL HILL CONSULTING GROUP
2011 · fourth_quarter · Q4
General patent issues; America Invents Act (S. 23)
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General FDA funding issues; FY2012 Labor-HHS-Education Appropriations; Pandemic vaccine issues
Federal Student Loans/Aid
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
General education issues; Federal Student Loans/Aid
General agriculture issues Federal research/competitive grants
2015 Defense Authorization bill
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
General health care issues pertaining to OSU CHS
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
General homeland security issues
General agriculture issues Federal research/competitive grants
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
General education issues; Federal Student Loans/Aid
General homeland security issues
Tax reform and charitable giving
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
Tax reform and charitable giving
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE
General agriculture issues
General homeland security issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General agriculture isses
General homeland security issues
2014 Defense Authorization bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2014 Defense Authorization bill
General appropriations for the University; FY 2014 Appropriations for agriculture, commerce, justice, science, defense, energy and water; financial services; Homeland Security reauthorization; Interior and Environment; Labor, HHS, and Education; Highway Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement
General FDA funding issues; FY 2014 Labor-HHS-Education Appropriations; Pandemic vaccine issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2014 Defense Authorization bill
General appropriations for the University; FY 2014 Appropriations for agriculture, commerce, justice, science, defense, energy and water; financial services; Homeland Security reauthorization; Interior and Environment; Labor, HHS, and Education; Highway Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Compounding pharmacy and FDA issues
Compounding pharmacy and FDA issues
Compounding pharmacy and FDA issues
Compounding pharmacy and FDA issues
General patent issues; America Invents Act (S. 23)
General FDA funding issues; FY 2013 Labor-HHS-Education Appropriations; Pandemic vaccine issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General appropriations for the University; FY 2013 Appropriations for agriculture, commerce, justice, science, defense, energy and water; financial services; Homeland Security reauthorization; Interior and Environment; Labor, HHS, and Education; Highway Reauthorization
2013 Defense Authorization bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Prescription and Generic Drug User Fees legislation; Public Health Service Act (42 USC 6A); Biosimilars; Patient Protection and Affordable Care Act (P.L. 111-148)
General FDA funding issues; FY2012 Labor-HHS-Education Appropriations; Pandemic vaccine issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General appropriations for the University; FY2012 Appropriations for agriculture, commerce, justice, science, defense, energy and water; financial services; Homeland Security reauthorization; Interior and Environment; Labor, HHS, and Education; Highway Reauthorization
General agriculture isses
2012 Defense Authorization bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General patent issues; America Invents Act (S. 23)
General FDA funding issues; FY2012 Labor-HHS-Education Appropriations; Pandemic vaccine issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 Defense Authorization bill
General agriculture isses
General transportation issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Biosimilars; Patient Protection and Affordable Care Act (P.L. 111-148)
H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, SENATE